Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Pancreatic Cancer: A Review and Update

Elizabeth Prechtel Dunphy
CJON 2008, 12(5), 735-741 DOI: 10.1188/08.CJON.735-741

Pancreatic cancer will account for about 6% of all cancer-related deaths in 2008. Patients often present with advanced disease, so treatment remains a challenge. This article will review the risk factors, pathology features, clinical symptoms, diagnosis and staging guidelines, treatment, and nursing implications of pancreatic cancer. This article also will review studies that have precipitated the shift in systemic treatment from 5-fluorouracil to gemcitabine. Targeted therapies will further shift treatment strategies to improve survival as more is learned about the molecular basis of pancreatic cancer.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or